cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
$pirs pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting #investing #trading
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i